Testosterone Replacement in Diabetes Mellitus with Vascular Disease
ISRCTN | ISRCTN07197979 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN07197979 |
Secondary identifying numbers | N0034170256 |
- Submission date
- 28/09/2007
- Registration date
- 28/09/2007
- Last edited
- 18/04/2012
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr TH Jones
Scientific
Scientific
Medicine
Barnsley District General Hospital NHS Trust
Gawber Road
Barnsley
S75 2EP
United Kingdom
Study information
Study design | Single centre randomised double blind placebo controlled parallel study |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | |
Study objectives | To the effect of 12 weeks of testosterone replacement, given as testosterone esters 200mg from Sustanon 250 IM injection, on arterial stiffness measured by ultrasound derived stiffness index B of the femoral artery in men with a combination of Diabetes Mellitus, Peripheral Vascular Disease and hypogonadism. |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Nutritional, Metabolic, Endocrine: Diabetes |
Intervention | Sustanon vs placebo |
Intervention type | Drug |
Pharmaceutical study type(s) | |
Phase | Not Specified |
Drug / device / biological / vaccine name(s) | Sustanon |
Primary outcome measure | The effectiveness of 12 weeks of testosterone replacement, given as testosterone esters 200mg from Sustanon 250 IM injection, on arterial stiffness measured by ultrasound derived stiffness index B of the femoral artery in men with a combination of Diabetes Mellitus, PVD and hypogonadism. |
Secondary outcome measures | The effects of testosterone on Glycated Haemoglobin. |
Overall study start date | 01/10/2005 |
Completion date | 01/06/2006 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Sex | Male |
Target number of participants | 30 |
Key inclusion criteria | 1. Men with Diabetes M, hypogonadism and PVD 2. Older than 40 years old 3.Type 2 Diabetes Mellitus treated with insulin with or without oral hypoglycaemics 4. Serum testosterone less than 12mmol/L on two consecutive morning samples taken on different days 5. Symptoms attributable to hypogonadism in the opinion of the investigator 6. Agreement to maintain, diabetic antihypertensive and antilipid treatments at prior doses for the duration of the study 7. Ability to give written informed consent and verbal and written explanation in the English language 8. Ability to comply with all study requirements |
Key exclusion criteria | 1. Current or previous breast cancer 2. Current or previous prostate cancer 3. Raised prostate specific antigen (PSA) or abnormal digital rectal examination suspicious of prostate cancer unless diagnosis excluded after specialist urology opinion and/or prostate biopsy 4. Severe symptoms of benign prostatic hypertrophy (prostatism) 5. Treatment with testosterone in the 3 months prior to the trial. 6. Investigational drug treatment in the 3 months prior to the trial 7. Any other reason considered significant by the investigators at the time of assessment |
Date of first enrolment | 01/10/2005 |
Date of final enrolment | 01/06/2006 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Medicine
Barnsley
S75 2EP
United Kingdom
S75 2EP
United Kingdom
Sponsor information
Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Government
Government
The Department of Health, Richmond House, 79 Whitehall
London
SW1A 2NL
United Kingdom
Phone | +44 (0)20 7307 2622 |
---|---|
dhmail@doh.gsi.org.uk | |
Website | http://www.dh.gov.uk/Home/fs/en |
Funders
Funder type
Government
Barnsley Hospital NHS Foundation Trust (UK)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 01/05/2007 | Yes | No |